
Molecular Characterization of Lys49 and Asp49 Phospholipases A2 from Snake Venom and Their Antiviral Activities against Dengue virus
2013; Multidisciplinary Digital Publishing Institute; Volume: 5; Issue: 10 Linguagem: Inglês
10.3390/toxins5101780
ISSN2072-6651
AutoresAlzira Batista Cecílio, Sérgio Caldas, Raiana Oliveira, Arthur Pereira dos Santos, Michael Richardson, Gustavo B. Naumann, Francisco Santos Schneider, Valéria Gonçalves de Alvarenga, Maria Inácia Estevão-Costa, Andre Fuly, Johannes A. Eble, Eládio F. Sanchez,
Tópico(s)Rabies epidemiology and control
ResumoWe report the detailed molecular characterization of two PLA2s, Lys49 and Asp49 isolated from Bothrops leucurus venom, and examined their effects against Dengue virus (DENV). The Bl-PLA2s, named BlK-PLA2 and BlD-PLA2, are composed of 121 and 122 amino acids determined by automated sequencing of the native proteins and peptides produced by digestion with trypsin. They contain fourteen cysteines with pIs of 9.05 and 8.18 for BlK- and BlD-PLA2s, and show a high degree of sequence similarity to homologous snake venom PLA2s, but may display different biological effects. Molecular masses of 13,689.220 (Lys49) and 13,978.386 (Asp49) were determined by mass spectrometry. DENV causes a prevalent arboviral disease in humans, and no clinically approved antiviral therapy is currently available to treat DENV infections. The maximum non-toxic concentration of the proteins to LLC-MK2 cells determined by MTT assay was 40 µg/mL for Bl-PLA2s (pool) and 20 µg/mL for each isoform. Antiviral effects of Bl-PLA2s were assessed by quantitative Real-Time PCR. Bl-PLA2s were able to reduce DENV-1, DENV-2, and DENV-3 serotypes in LLC-MK2 cells infection. Our data provide further insight into the structural properties and their antiviral activity against DENV, opening up possibilities for biotechnological applications of these Bl-PLA2s as tools of research.
Referência(s)